RecruitingNot applicableNCT06891755
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
Sponsor: Apreo Health, Inc.
Jascksonville, FL · Orlando, FL · +16 more sites
COPD clinical trials in Orlando, FL
9 recruiting copd studies with a site in Orlando, FL.
RecruitingPhase 3NCT07190209
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Sponsor: Sanofi
Boynton Beach, FL · Cutler Bay, FL · Doral, FL · +72 more sites
RecruitingPhase 2NCT07759245
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
Sponsor: Eli Lilly and Company
Miami, FL · Miami Lakes, FL · Orlando, FL · +15 more sites
RecruitingPhase 3NCT06961214
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Sponsor: GlaxoSmithKline
Brooksville, FL · Doral, FL · Fort Lauderdale, FL · +54 more sites
RecruitingPhase 3NCT06283966
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Sponsor: AstraZeneca
Boynton Beach, FL · Bradenton, FL · Cape Coral, FL · +232 more sites
RecruitingPhase 3NCT07190222
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Sponsor: Sanofi
Brandon, FL · DeLand, FL · Greenacres City, FL · +73 more sites
RecruitingNot applicableNCT06035120
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
Sponsor: Pulmonx Corporation
Orlando, FL · +19 more sites
RecruitingPhase 3NCT06883305
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Sponsor: AstraZeneca
Clearwater, FL · Cutler Bay, FL · +70 more sites
RecruitingPhase 3NCT07177339
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Sponsor: GlaxoSmithKline
Brandon, FL · Crystal River, FL · Doral, FL · +39 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.